Explore the categories so you can find more about your search.
Categorie > Crohn's
Having A Pet Pig May Offer Some Benefits
Categorie : Crohn'sContact with farm environments in infancy might decrease the risk of juvenile Crohn's disease and ulcerative colitis. That's according to a study conducted in Germany entitled, "Contact With Farm Animals in Early Life and Juvenile Inflammatory Bowel Disease: A Case-Control Study." Parents of chi ...
read more 
Sun Oct 2007
Joint FDA Advisory Committee Recommends Approval Of TYSABRI® For The Treatment Of Moderate To Severe Crohn's Disease
Categorie : Crohn'sElan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced today that the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the U.S. Food and Drug Administration (FDA) voted 12 in favor to 3 opposed, with 2 abstaining, to recommen ...
read more Sun Oct 2007
Effective Strategy In IBD Patients Found To Be Infliximab Scheduled Treatment
Categorie : Crohn'sCrohn's disease (CD) and ulcerative colitis (UC) are chronic-relapsing diseases, the clinical courses of which are characterized by periods of remission and periods of acute flare up, determining clinical symptoms which have a strong impact on the quality of life for patients. [click link for fu ...
read more Sun Oct 2007
Elan And Biogen Idec Announce That Fda Will Extend Regulatory Review Period For Tysabri® For Crohn's Disease
Categorie : Crohn'sElan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) informed the companies that the Agency will extend its regulatory review of TYSABRI® (natalizumab) as a treatment for Crohn's disease by up to 3 months.The companies have ...
read more Sun Oct 2007
Endoscopy Via Capsule Is Turning Up Undiagnosed Cases Of Crohn's Disease
Categorie : Crohn'sA small capsule that takes "snapshots" of the small intestine as it moves through the digestive tract helped doctors spot cases of Crohn's disease that had gone undiagnosed for up to 15 years, according to researchers at Wake Forest University Baptist Medical Center. [click link for full article] ...
read more Sun Oct 2007
Asacol® 800mg Mr Tablets Approved For Ulcerative Colitis (UC), Maintenance Of Remission Of UC And Crohn's Ileo-Colitis
Categorie : Crohn'sProcter & Gamble Pharmaceuticals (NYSE: P&G)announced today that Asacol® (mesalazine) 800mg Modified Release (MR) tablets have beenapproved for the treatment of mild to moderate ulcerative colitis (UC) and maintenance ofremission of UC and Crohn's ileo-colitis in the United Kingdom ...
read more Sun Oct 2007
First-Step Test For Patients With Crohn's Disease Should Be PET/CT
Categorie : Crohn'sThe molecular imaging power of PET/CT is invaluable in noninvasively monitoring Crohn's disease - a chronic inflammatory disease of the gastrointestinal tract that mainly affects young people, according to a study released by Belgian scientists at the 54th Annual Meeting of SNM, the world's largest ...
read more Fri Jun 2007
Abbott's HUMIRA® (Adalimumab) Approved In The European Union For The Treatment Of Crohn's Disease
Categorie : Crohn'sAbbott announced today that it has received marketing authorization from the European Commission for the use of HUMIRA® (adalimumab) as a treatment for severe Crohn's disease. HUMIRA is the first self-administered biologic for the treatment of Crohn's disease and offers an effective and convenient ...
read more Fri Jun 2007
Remicade(R) Receives EU Approval As First And Only Biologic Treatment For Pediatric Crohn's Disease
Categorie : Crohn'sCentocor, Inc. and Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission has approved a new indication for REMICADE(R) (infliximab) allowing for the treatment of severe, active Crohn's disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to ...
read more Fri Jun 2007
Large Genome Study Finds Genes Behind Common Diseases
Categorie : Crohn'sIn the largest ever study published to date, a consortium of UK scientists has discovered over 20 genes and regions of the human genome that contribute to diseases such as diabetes, rheumatoid arthritis and coronary heart disease.The Wellcome Trust Control Consortium's 9 million pound study is a col ...
read more Thu Jun 2007
In Crohn's Disease CEACAM6 Helps E. Coli Stick To Intestinal Lining
Categorie : Crohn'sIn Crohn's disease, the lining of the small intestine is abnormally colonized by E. coli organisms that are able to adhere to and invade intestinal epithelial cells. In a study appearing online in advance of publication in the June print issue of the Journal of Clinical Investigation, Arlette Darfeu ...
read more Thu May 2007
New Analysis Of Data Shows Treatment With Abbott's HUMIRA® Significantly Reduced Disease-Related Hospitalization For Patients With Crohn's
Categorie : Crohn'sAbbott today announced results from a post-hoc analysis of a pivotal study presented at the Digestive Disease Week annual meeting in Washington, D.C. showing patients with moderate to severely active Crohn's disease treated with HUMIRA® (adalimumab) maintenance therapy were almost 60 percent less li ...
read more Thu May 2007
Capsule Endoscopy Is Effective In Diagnosing Childhood GI Problems
Categorie : Crohn'sResearchers at Jefferson Medical College have shown that capsule endoscopy is effective in diagnosing gastrointestinal bleeding and small bowel Crohn's disease in children. The technology has been used successfully at Thomas Jefferson University Hospital for more than five years to diagnose unexplai ...
read more Thu May 2007
UCB Presents Long-Term CIMZIA(TM) Data In Crohn's Disease
Categorie : Crohn'sUCB announced today that new data presented at Digestive Disease Week 2007 (DDW) demonstrated long-term response and remission in Crohn's disease patients treated with CIMZIA(TM) (certolizumab pegol), the only Fc-free PEGylated, Fab' fragment anti-TNF. The study, called PRECiSE 3 (P3), is a long- ...
read more Wed May 2007
New Therapy For Patients With Crohn's Disease Identified By Researchers
Categorie : Crohn'sA study led by Mayo Clinic found that adalimumab (HUMIRA®)) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE®) therapy. These findings were published online by Annals of Internal Medicine.Crohn's disease is an inflammatory disorder of the gastroint ...
read more Mon May 2007
Smoking Influences Crohn's Disease - Effect Seen On Location, Severity Of The Disease In The Gastrointestinal Tract
Categorie : Crohn'sA new study in The American Journal of Gastroenterology suggests that smoking may determine which part of the intestinal tract is attacked in those who suffer from Crohn's disease. Where the disease is located often determines whether the patient will eventually require surgical treatment. "In pati ...
read more Thu May 2007
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency For The Treatment Of Crohn's Disease
Categorie : Crohn'sAbbott announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA(R) (adalimumab) for the treatment of severe Crohn's disease. HUMIRA will be the first s ...
read more Wed May 2007
Abbott's HUMIRA® (adalimumab) Receives Positive Opinion From European Medicines Agency For The Treatment Of Crohnâ?˛s Disease
Categorie : Crohn'sAbbott announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA® (adalimumab) for the treatment of severe Crohnâ?˛s disease. HUMIRA will be the first se ...
read more Mon Apr 2007
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From European Medicines Agency For The Treatment Of Crohn´s Disease
Categorie : Crohn'sAbbott announced today that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), granted a positive opinion recommending approval of HUMIRA(R) (adalimumab) for the treatment of severe Crohn's disease. HUMIRA will be the first s ...
read more Sat Apr 2007
An Important New Clue In Susceptibility To Crohn's Disease
Categorie : Crohn'sCrohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain and diarrhea, but the disorder is often associated with debilitating clinical complications. Researchers from ...
read more Sun Apr 2007
Custom Search
